Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Umang Swami"'
Autor:
Adriana M Coletta, Lea Haverbeck Simon, Kelsey Maslana, Sarah Taylor, Kish Larson, Pamela A Hansen, Vinay Mathew Thomas, Cornelia M Ulrich, Manish Kohli, Jonathan Chipman, Umang Swami, Sumati Gupta, Benjamin L Maughan, Neeraj Agarwal
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Muscle mass is important for metastatic prostate cancer survival and quality of life (QoL). The backbone of treatment for men with metastatic castration sensitive prostate cancer (mCSPC) is androgen deprivation therapy (ADT) with
Externí odkaz:
https://doaj.org/article/413bb50587144df8982c00011578ce4c
Autor:
Nishita Tripathi, Georges Gebrael, Beverly Chigarira, Kamal Kant Sahu, Ishwarya Balasubramanian, Constance Caparas, Vinay Mathew Thomas, Jessica N. Cohan, Kaitlyn Pelletier, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami, Sumati Gupta
Publikováno v:
Cancers, Vol 16, Iss 11, p 2143 (2024)
Metastatic urinary tract cancer (mUTC) is challenging to treat in older adults due to comorbidities. We compared the clinical courses of younger and older (≥70 years) adults with mUTC receiving first-line (1L) systemic therapy in a tertiary cancer
Externí odkaz:
https://doaj.org/article/6122aada0ce7482e977b9ba460b507e8
Autor:
Siwen Hu-Lieskovan, Ngan Nguyen, Magdalena Kovacsovics-Bankowski, John Hyngstrom, Li-Chun Cheng, Jordan P McPherson, Umang Swami, Matthew H Spitzer, Johanna M Sweere, Connor P Healy, Natalia Sigal, William D Chronister, Shane A Evans, John Marsiglio, Berit Gibson, Alyssa Erickson-Wayman, Yoko S Derose, Annaleah Larson Eliason, Carlos O Medina, Ramji Srinivasan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)
Background Immune-related adverse events (irAEs) are major barriers of clinical management and further development of immune checkpoint inhibitors (ICIs) for cancer therapy. Therefore, biomarkers associated with the onset of severe irAEs are needed.
Externí odkaz:
https://doaj.org/article/33adf4f87d5845b590a6128eac8e0678
Autor:
John Marsiglio, Jordan P. McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami, Douglas Grossmann, Alyssa Erickson-Wayman, Heloisa P. Soares, Katie Kerrigan, Berit Gibson, Jennifer Anne Doherty, John Hyngstrom, Sheetal Hardikar, Siwen Hu-Lieskovan
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundType 1 diabetes mellitus (T1DM) is a rare, but serious immune-related adverse event (irAE) of immune checkpoint inhibitors (ICIs). Our goal was to characterize treatment outcomes associated with ICI-induced T1DM through analysis of clinical
Externí odkaz:
https://doaj.org/article/33e51152bcc24a469b71e51e480b2741
Autor:
Ignacio Garrido-Laguna, Asaf Maoz, Wungki Park, Abdul Rafeh Naqash, Vaia Florou, Breelyn Wilky, Jonathan Trent, Umang Swami, Garrett Frampton, Heloisa P Soares, Sonam Puri, Aik Choon Tan, Charalampos S Floudas, Carter Norton, Ethan S Sokol, Peter Hosein, Gilberto de Lima Lopes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 8 (2023)
Background Pembrolizumab is FDA approved for tumors with tumor mutational burden (TMB) of ≥10 mutations/megabase (mut/Mb). However, the response to immune checkpoint inhibitors (ICI) varies significantly among cancer histologies. We describe the la
Externí odkaz:
https://doaj.org/article/206cd2d9903d405d9e63f577bd3f9aea
Publikováno v:
Life, Vol 14, Iss 2, p 198 (2024)
The treatment landscape of metastatic prostate cancer (mPCa) is rapidly evolving with the recent approvals of poly-ADP ribose polymerase inhibitors (PARPis) as monotherapy or as part of combination therapy with androgen receptor pathway inhibitors in
Externí odkaz:
https://doaj.org/article/2047f63304e4412889809a1f9f51b290
Autor:
Morgan B. Marshall, Kassandra Dindinger-Hill, Umang Swami, Stephanie Lyden, Alejandro Sanchez
Publikováno v:
Urology Case Reports, Vol 48, Iss , Pp 102427- (2023)
A 25-year-old male was admitted to the neurological intensive care unit for neurologic deterioration, likely caused by a paraneoplastic syndrome secondary to testicular malignancy. He experienced spontaneous rupture and hemorrhage of his testicular m
Externí odkaz:
https://doaj.org/article/ed87c797df9a4e4ebf67ac8f35cfdc08
Autor:
Haoran Li, Kamal Kant Sahu, Shruti Adidam Kumar, Nishita Tripathi, Nicolas Sayegh, Blake Nordblad, Beverly Chigarira, Sumati Gupta, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami
Publikováno v:
Cancers, Vol 15, Iss 21, p 5171 (2023)
Compared to the urban population, patients in rural areas face healthcare disparities and experience inferior healthcare-related outcomes. To compare the healthcare quality metrics and outcomes between patients with advanced genitourinary cancers fro
Externí odkaz:
https://doaj.org/article/eaf7be66ca8d4829a72627d403ed9483
Autor:
Georges Gebrael, Kamal Kant Sahu, Beverly Chigarira, Nishita Tripathi, Vinay Mathew Thomas, Nicolas Sayegh, Benjamin L. Maughan, Neeraj Agarwal, Umang Swami, Haoran Li
Publikováno v:
Cancers, Vol 15, Iss 14, p 3717 (2023)
Background: Accurate and efficient triage is crucial for prioritizing care and managing resources in emergency rooms. This study investigates the effectiveness of ChatGPT, an advanced artificial intelligence system, in assisting health providers with
Externí odkaz:
https://doaj.org/article/c35b80641eab454f9ba8b09fc8095592
Autor:
Umang Swami, Raquel Mae Zimmerman, Roberto H. Nussenzveig, Edgar Javier Hernandez, Yeonjung Jo, Nicolas Sayegh, Sergiusz Wesolowski, Lesli A. Kiedrowski, Pedro C. Barata, Gordon Howard Lemmon, Mehmet A. Bilen, Elisabeth I. Heath, Lakshminarayan Nandagopal, Hani M. Babiker, Sumanta K. Pal, Michael Lilly, Benjamin L. Maughan, Benjamin Haaland, Mark Yandell, Oliver Sartor, Neeraj Agarwal
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BRCA1-mutated prostate cancer has been shown to be less responsive to poly (ADP-ribose) polymerase (PARP) inhibitors as compared to BRCA2-mutated prostate cancer. The reason for this differential response is not clear. We hypothesized this differenti
Externí odkaz:
https://doaj.org/article/4e03b0f2c01f46158e4c977641bd2a04